“Hook effect and serum KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)” (2021) International Journal of Integrated Health Sciences, 9(2), pp. 66–72. doi:10.15850/ijihs.v9n2.2488.